The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Combivir and Videx
Dec 12, 2003

(CD4 307, VL 33k, Treatment has not yet started.)

Are Combivir and Videx a good combination for initial HIV treatment? One doctor said "not really," another doctor said, "definitely not," and a third prescribed the drugs. (Another question made reference to this problem, but the answer was not clear.)

Would Combivir and Abacavir (i.e., Trizivir) be an optimal combination?

Or should an NNRTI like Sustiva also be specifically requested?

Response from Dr. Pierone

The use of a triple nucleoside combination for treatment of HIV infection is not really the best regimen based on available studies. However, there are many patients that have been on triple nuke therapy for years and have done great with controlled virus and no problems.

Comparative studies have shown the NNRTI-based therapy tend to result in a higher rate of patients with controlled virus than triple nuke regimens. So the DHHS treatment guidelines have recommended NNRTI-based therapy as preferred over triple nucleoside combinations.

RE: PI equals heart damage
med combinations and vaccines

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint